Resources

These recommendations support the need for a cohesive national approach to the implementation of genomics into the Australian health system

This fact sheet is for current and future patients with Fabry disease explaining how a treatment for this condition, migalastat (Galafold®), will be transitioning from the Life Saving Drugs Program to the PBS. The fact sheet further provides clarity on future access arrangements via the PBS.

This fact sheet is for current prescribers (treating physicians) with patients requiring treatment for Fabry disease. The fact sheet explains how a treatment for this condition, migalastat (Galafold®), will be transitioning from the Life Saving Drugs Program to the PBS.

This communique summarises the meeting of the Expert Advisory Group on Genomics Australia, held on 21 June 2024.

This communique summarises the meeting of the Expert Advisory Group on Genomics Australia, held on 30 November 2023.

These documents outline the goals and investment priorities of the Genomics Health Futures Mission. The Genomics Health Futures Mission is a Medical Research Future Fund (MRFF) initiative.

This communique summarises the meeting of the Expert Advisory Group on Genomics Australia, held on 29 August 2023.

This communique summarises the meeting of the Expert Advisory Group on Genomics Australia, held on 2 August 2023.

Terms of reference for the Expert Advisory Group on Genomics Australia.

This report contains the key findings from the Genetic Counselling Working Group (GCWG).

This issues paper identifies the ethical, legal, social and cultural issues surrounding the collection and use of Aboriginal and Torres Strait Islander genomic material and data in both clinical and research settings.

A Budget 2022–23 fact sheet.

A Budget 2022–23 fact sheet.

This Communicable Diseases Genomics Network (CDGN), Public Health Laboratory Network (PHLN) and Communicable Diseases Network Australia (CDNA) document contains a sampling strategy for SARS-CoV-2 genomic surveillance.

This report summarises the outcomes of the Genomics Health Futures Mission International Review Panel meeting on 11 November 2020. The panel met to inform the strategic direction of the Genomics Health Futures Mission’s Roadmap and Implementation Plan.

This report summarises the national consultation on the Genomics Health Futures Mission Roadmap and Implementation Plan conducted between 14 December 2020 and 23 April 2021.

This implementation plan identifies actions, responsibilities, time frames, priorities and resourcing requirements for the integration of microbial genomics into the Australian public health system. It sits under the National Microbial Genomics Framework 2019–2022.

This report presents the results of post-market validation of the Beijing Genomics Institute SARS-CoV-2 Real time PCR test kit.

Statement from the Standing Committee on Screening about the possible use of genetic or genomic technologies in population-based screening programs.

This final report outlines what The Royal College of Pathologists of Australasia (RCPA) genetic and genomic certification project achieved.

This snapshot shows this Mission at a glance. It includes budgets, early funding priorities and grant timelines, as at November 2019. Researchers and other stakeholders can use it to plan for upcoming opportunities and see how the Mission will be established, expanded and embedded over time.